Drug Resistance in Cancer Cells

An estimated 1.5 million patients in the United States are diagnosed with cancer every year and over half-a-million individuals die of the disease. Since the vast majority of the deaths occur after medical intervention with anticancer therapy, both conventional chemotherapy and novel targeted therap...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Siddik, Zahid H. (Επιμελητής έκδοσης), Mehta, Kapil (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New York, NY : Springer US, 2009.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Multidrug Resistance Mediated by MDR-ABC Transporters
  • Metastasis and Drug Resistance
  • The Role of Autophagy and Apoptosis in the Drug Resistance of Cancer
  • Mechanisms of Resistance to Targeted Tyrosine Kinase Inhibitors
  • Targeting Transglutaminase-2 to Overcome Chemoresistance in Cancer Cells
  • Extracellular Matrix-Mediated Drug Resistance
  • Oxidative Stress and Drug Resistance in Cancer
  • Nuclear Factor-?B and Chemoresistance: How Intertwined Are They?
  • Drug Resistance and the Tumor Suppressor p53: The Paradox of Wild-Type Genotype in Chemorefractory Cancers
  • Resistance to Differentiation Therapy
  • MicroRNAs and Drug Resistance
  • Molecular Signatures of Drug Resistance
  • Assessment of Drug Resistance in Anticancer Therapy by Nuclear Imaging
  • Overcoming Drug Resistance by Phytochemicals.